Sandy Spring Bank’s Champions Oncology CSBR Stock Holding History

Sandy Spring Bank’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-26,250	Closed	-$148K	–	841
2019 Q3	$148K	Hold	26,250	–	–	0.01%	325
2019 Q2	$206K	Hold	26,250	–	–	0.02%	293
2019 Q1	$257K	Hold	26,250	–	–	0.02%	271
2018 Q4	$205K	Buy	+26,250	New	+$301K	0.02%	281
2018 Q3	–	Sell	-8,333	Closed	-$53K	–	776
2018 Q2	$53K	Hold	8,333	–	–	﹤0.01%	459
2018 Q1	$30K	Hold	8,333	–	–	﹤0.01%	539
2017 Q4	$32K	Hold	8,333	–	–	﹤0.01%	512
2017 Q3	$31K	Hold	8,333	–	–	﹤0.01%	506
2017 Q2	$21K	Hold	8,333	–	–	﹤0.01%	576
2017 Q1	$26K	Hold	8,333	–	–	﹤0.01%	550
2016 Q4	$21K	Hold	8,333	–	–	﹤0.01%	562
2016 Q3	$14K	Hold	8,333	–	–	﹤0.01%	590
2016 Q2	$18K	Hold	8,333	–	–	﹤0.01%	567
2016 Q1	$30K	Hold	8,333	–	–	﹤0.01%	518
2015 Q4	$30K	Buy	+8,333	New	+$35.8K	﹤0.01%	495

Other funds holding CSBR

BPI

Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sandy Spring Bank's CSBR Position: Q4 2019 in Review

Sandy Spring Bank sold out of Champions Oncology (CSBR) in Q4 2019, closing a stake of 26,250 shares — an estimated $148K sold.

Sandy Spring Bank first reported a position in CSBR in Q4 2015 and held it in 15 quarters. The position peaked at $257K in Q1 2019. 32 funds tracked by Wall St. Rank hold CSBR as of Q4 2019.

Sandy Spring Bank reported no remaining Champions Oncology position as of Q4 2019 after selling out during the quarter.
Sandy Spring Bank sold 26,250 Champions Oncology shares in Q4 2019, an estimated $148K.
Sandy Spring Bank first reported a position in Champions Oncology in Q4 2015 and held it in 15 quarters.
Sandy Spring Bank's Champions Oncology position peaked at $257K in Q1 2019.
32 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2019.

Based on Sandy Spring Bank's 13F filing for Q4 2019, filed 6 Feb 2020.